BFRI
Price
$0.96
Change
-$0.00 (-0.00%)
Updated
Sep 26 closing price
Capitalization
10.24M
CRON
Price
$2.63
Change
-$0.01 (-0.38%)
Updated
Sep 26 closing price
Capitalization
1B
38 days until earnings call
Interact to see
Advertisement

BFRI vs CRON

Header iconBFRI vs CRON Comparison
Open Charts BFRI vs CRONBanner chart's image
Biofrontera
Price$0.96
Change-$0.00 (-0.00%)
Volume$20.39K
Capitalization10.24M
Cronos Group
Price$2.63
Change-$0.01 (-0.38%)
Volume$904.21K
Capitalization1B
BFRI vs CRON Comparison Chart in %
Loading...
BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BFRI vs. CRON commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFRI is a Hold and CRON is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 28, 2025
Stock price -- (BFRI: $0.96 vs. CRON: $2.63)
Brand notoriety: BFRI and CRON are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BFRI: 9% vs. CRON: 33%
Market capitalization -- BFRI: $10.24M vs. CRON: $1B
BFRI [@Pharmaceuticals: Generic] is valued at $10.24M. CRON’s [@Pharmaceuticals: Generic] market capitalization is $1B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BFRI’s FA Score shows that 1 FA rating(s) are green whileCRON’s FA Score has 1 green FA rating(s).

  • BFRI’s FA Score: 1 green, 4 red.
  • CRON’s FA Score: 1 green, 4 red.
According to our system of comparison, both BFRI and CRON are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BFRI’s TA Score shows that 6 TA indicator(s) are bullish while CRON’s TA Score has 3 bullish TA indicator(s).

  • BFRI’s TA Score: 6 bullish, 5 bearish.
  • CRON’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BFRI is a better buy in the short-term than CRON.

Price Growth

BFRI (@Pharmaceuticals: Generic) experienced а +6.66% price change this week, while CRON (@Pharmaceuticals: Generic) price change was +0.38% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -1.16%. For the same industry, the average monthly price growth was +24.25%, and the average quarterly price growth was +66.99%.

Reported Earning Dates

CRON is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (-1.16% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRON($1B) has a higher market cap than BFRI($10.2M). CRON has higher P/E ratio than BFRI: CRON (52.60) vs BFRI (0.89). CRON YTD gains are higher at: 30.198 vs. BFRI (-11.936). BFRI has higher annual earnings (EBITDA): -15.28M vs. CRON (-25.58M). CRON has more cash in the bank: 834M vs. BFRI (7.25M). CRON has less debt than BFRI: CRON (2.01M) vs BFRI (5M). CRON has higher revenues than BFRI: CRON (130M) vs BFRI (39.2M).
BFRICRONBFRI / CRON
Capitalization10.2M1B1%
EBITDA-15.28M-25.58M60%
Gain YTD-11.93630.198-40%
P/E Ratio0.8952.602%
Revenue39.2M130M30%
Total Cash7.25M834M1%
Total Debt5M2.01M249%
FUNDAMENTALS RATINGS
CRON: Fundamental Ratings
CRON
OUTLOOK RATING
1..100
91
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BFRICRON
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
85%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
76%
Advances
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 5 days ago
71%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
BFRI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BMEA2.100.05
+2.44%
Biomea Fusion
VKTX25.570.48
+1.91%
Viking Therapeutics
SYNX1.490.02
+1.36%
Silynxcom Ltd
GDDY141.400.21
+0.15%
GoDaddy
MAX12.04-0.02
-0.17%
MediaAlpha

BFRI and

Correlation & Price change

A.I.dvisor tells us that BFRI and RDHL have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BFRI and RDHL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BFRI
1D Price
Change %
BFRI100%
-0.02%
RDHL - BFRI
23%
Poorly correlated
+11.52%
COLL - BFRI
21%
Poorly correlated
-0.69%
TLRY - BFRI
21%
Poorly correlated
-3.36%
CRON - BFRI
20%
Poorly correlated
-0.38%
KMDA - BFRI
20%
Poorly correlated
-0.30%
More

CRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRON has been loosely correlated with TLRY. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if CRON jumps, then TLRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRON
1D Price
Change %
CRON100%
-0.38%
TLRY - CRON
60%
Loosely correlated
-3.36%
OGI - CRON
59%
Loosely correlated
-3.43%
CGC - CRON
57%
Loosely correlated
-2.19%
ACB - CRON
54%
Loosely correlated
-1.82%
EBS - CRON
31%
Poorly correlated
+1.95%
More